RANK-L and RANK: T cells, bone loss, and mammalian evolution
- PMID: 11861618
- DOI: 10.1146/annurev.immunol.20.100301.064753
RANK-L and RANK: T cells, bone loss, and mammalian evolution
Abstract
TNF and TNFR family proteins play important roles in the control of cell death, proliferation, autoimmunity, the function of immune cells, or the organogenesis of lymphoid organs. Recently, novel members of this large family have been identified that have critical functions in immunity and that couple lymphoid cells with other organ systems such as bone morphogenesis and mammary gland formation in pregnancy. The TNF-family molecule RANK-L (RANK-L, TRANCE, ODF) and its receptor RANK are key regulators of bone remodeling, and they are essential for the development and activation of osteoclasts. Intriguingly, RANK-L/RANK interactions also regulate T cell/dendritic cell communications, dendritic cell survival, and lymph node formation; T cell-derived RANK-L can mediate bone loss in arthritis and periodontal disease. Moreover, RANK-L and RANK are expressed in mammary gland epithelial cells, and they control the development of a lactating mammary gland during pregnancy and the propagation of mammalian species. Modulation of these systems provides us with a unique opportunity to design novel therapeutics to inhibit bone loss in arthritis, periodontal disease, and osteoporosis.
Similar articles
-
Role of RANKL and RANK in bone loss and arthritis.Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii32-9. doi: 10.1136/ard.61.suppl_2.ii32. Ann Rheum Dis. 2002. PMID: 12379618 Free PMC article. Review.
-
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.Nature. 1999 Nov 18;402(6759):304-9. doi: 10.1038/46303. Nature. 1999. PMID: 10580503
-
RANKL and RANK as novel therapeutic targets for arthritis.Curr Opin Rheumatol. 2003 May;15(3):280-7. doi: 10.1097/00002281-200305000-00016. Curr Opin Rheumatol. 2003. PMID: 12707582 Review.
-
[The OPG/RANKL/RANK system and bone resorptive disease].Sheng Wu Gong Cheng Xue Bao. 2003 Nov;19(6):655-60. Sheng Wu Gong Cheng Xue Bao. 2003. PMID: 15971575 Review. Chinese.
-
RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.Cancer. 2003 Feb 1;97(3 Suppl):802-12. doi: 10.1002/cncr.11134. Cancer. 2003. PMID: 12548579 Review.
Cited by
-
Immunohistochemical and molecular characterization of the human periosteum.ScientificWorldJournal. 2013 May 2;2013:341078. doi: 10.1155/2013/341078. Print 2013. ScientificWorldJournal. 2013. PMID: 23737713 Free PMC article.
-
Modulating macrophage activities to promote endogenous bone regeneration: Biological mechanisms and engineering approaches.Bioact Mater. 2020 Aug 22;6(1):244-261. doi: 10.1016/j.bioactmat.2020.08.012. eCollection 2021 Jan. Bioact Mater. 2020. PMID: 32913932 Free PMC article. Review.
-
Stem cell-mediated osteogenesis: therapeutic potential for bone tissue engineering.Biologics. 2012;6:47-57. doi: 10.2147/BTT.S22407. Epub 2012 Mar 9. Biologics. 2012. PMID: 22500114 Free PMC article.
-
Osteoporosis: Pathophysiology and therapeutic options.EXCLI J. 2020 Jul 20;19:1017-1037. doi: 10.17179/excli2020-2591. eCollection 2020. EXCLI J. 2020. PMID: 32788914 Free PMC article. Review.
-
DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway.Nat Med. 2015 Mar;21(3):281-7. doi: 10.1038/nm.3774. Epub 2015 Feb 23. Nat Med. 2015. PMID: 25706873
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources